Bellerophon Therapeutics Inc.

(BLPH) Trade

By |

Profile

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Contact Information

Website: www.bellerophon.com
Email: christine.viau@bmo.com
Main Phone: +1 908 574-4770
Address: 184 Liberty Corner Road
Address 2: Suite 302
State: NJ
City / Town: Warren
Country: USA
Postal Code: 07059

Issuer Information

Exchange: NSD
CEO: Fabian Tenenbaum
Employees: 20
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.15 $ -0.03 (-2.54%)
Last Price 1.15 Change $ -0.03 Change % -2.54 Tick N/A
Bid 1.15 Bid Size 1,800.00 Ask 1.18 Ask Size 3,600.00
Open 1.20 High 1.20 Low 1.15 Prev Close 1.18
Last Trade Volume 73,306 52 Wk Hi 3.30 52 Wk Low 0.47
Market Cap 66.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 57,798,637.00 EPS (TTM) -0.95 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 24
Number of Buys 1 20
Number of Sells 0 4
Net Activity 99010 1803779
Last 10 Buys Shares
Jens Luehring 1,000
Jens Luehring 1,000
Naseem Amin 1,000
Jonathan M. Peacock 1,000
Jonathan M. Peacock 1,000
Naseem Amin 1,000
Jens Luehring 1,000
Jonathan M. Peacock 1,000
Jonathan M. Peacock 1,000
Naseem Amin 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/10/17 08/10/17 08/10/17 08/10/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 0